Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04080570 · ClinicalTrials.gov registry record · NA
Remote Physician Care for Home Hospital Patients
A NA study of Heart Failure and Asthma, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 172
- Enrollment target
- 2
- Study locations
NCT04080570: Completed NA study of Heart Failure and Asthma, sponsored by Brigham and Women's Hospital.
NCT04080570 is a NA study of Heart Failure and Asthma that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 172 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04080570, a NA study of Heart Failure and Asthma, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study examines the implications of providing remote physician care to home hospitalized patients compared to usual home hospital care with in-person/in-home physician visits.
Primary Outcome
The per patient count of adverse events, including fall, delirium, potentially preventable venous thromboembolism, new pressure ulcer, thrombophlebitis at peripheral IV site, catheter-associated urinary tract infection, new Clostridium difficile, new methicillin-resistant Staphylococcus aureus, new arrhythmia, hypokalemia, acute kidney injury, transfer back to hospital, mortality (unplanned) during admission, mortality (unplanned) 30-day post-discharge.
Conditions Studied
Interventions
- OTHER Remote Visit
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
- Brigham and Women's Faulkner Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2019-08-03 |
| Est. Completion | 2020-04-27 |
| Phase | NA |
What the finished NCT04080570 record still lists
NCT04080570 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower).
The record links to 9 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Remote Visit is the first listed.
NCT04080570 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04080570 about?
NCT04080570 is a clinical study titled "Remote Physician Care for Home Hospital Patients". This study examines the implications of providing remote physician care to home hospitalized patients compared to usual home hospital care with in-person/in-home physician visits.
What is the current status of trial NCT04080570?
This trial is currently completed. It is a NA study. The enrollment target is 172 participants. The study started on 2019-08-03. Estimated completion is 2020-04-27.
What conditions does trial NCT04080570 study?
This clinical trial studies the following conditions: Heart Failure, Asthma, Chronic Obstructive Pulmonary Disease, Chronic Kidney Diseases, Infection.
What interventions are being tested in trial NCT04080570?
The interventions under investigation include: Remote Visit (OTHER).
Who is sponsoring clinical trial NCT04080570?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04080570 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04080570's enrollment target sits among peer trials
172 179th of 397 higher than 218 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI